Samir Z Zard

This inventor holds 24 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 5 EPO patents, primarily in Polymer Synthesis. Top assignees: Rhodia Chimie, Roussel Uclaf, Ilypsa, Inc.. Active years: 1984-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samir Z Zard. Retrieved from https://idiyas.com/inventor/samir-z-zard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 1)

% Patents Active = 70.8

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 3.5

ph-index = 10

Forward Citations = 351(Granted Patents)

Location History:

Gig sur Yvette, FR (2009)
Gif-Sur-Yvette, FR (1984 - 2016)

Company Filing History:

Les Laboratoires Servier

Centre National De La Recherche Scientifique

patents

7. 1 out of 53

Les Laboratories Servier

patents

Years Active: 1984-2016

Loading Chart...

Areas of Expertise:

Agomelatine Synthesis

Thiocarbonyl Compounds

Controlled Radical Polymerization

Polyamine Polymers

Hybrid Silicon Copolymers

Block Polymer Synthesis

Dithiocarbonyl Functions

Xanthate Reactants

Transesterification

Dithioester Compounds

Free Radical Reduction

Oxazolyl Steroids

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE46218 - Process for the synthesis of agomelatine (2016-11-28),

2. 8871975 - Process for the synthesis of agomelatine (2014-10-28),

3. 8853449 - Process for the synthesis of agomelatine (2014-10-07),

4. 7820831 - Compounds comprising a thiocarbonyl-sulfanyl group which can be used for the radical synthesis of α-perfluoroalkylamine compounds (2010-10-26),

5. 7473740 - Method for partial or total oxidation of one or several thiocarbonylthio ends of a polymer obtained by radical polymerisation controlled by reversible addition-fragmentation (2009-01-06),

6. 7423161 - Compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of-α-perfluoroalkylamines (2008-09-09),

7. 7396901 - Method for synthesis of polymers with thiol functions (2008-07-08),

8. 7385012 - Polyamine polymers (2008-06-10),

9. 7342083 - Polyamine polymers (2008-03-11),

10. 7285610 - Synthesis method for polymers by controlled radical polymerisation with xanthates (2007-10-23),

11. 7109276 - Method for free radical reduction of dithiocarbonylated or dithiophosphorylated functions borne by a polymer (2006-09-19),

12. 6858696 - Method for synthesis of hybrid silicon and organic copolymers by controlled free radical polymerization (2005-02-22),

13. 6812291 - Method for block polymer synthesis by controlled radical polymerization from dithiocarbamate compounds (2004-11-02),

14. 6809164 - Synthesis method for polymers by controlled radical polymerisation with xanthates (2004-10-26),

15. 6777513 - Synthesis method for polymers by controlled radical polymerisation using halogenated xanthates (2004-08-17),

Title: Exploring the Innovations of Samir Z. Zard

Introduction: Samir Z. Zard, based in Gif-sur-Yvette, France, is a prominent inventor known for his significant contributions to the field of chemistry. With a remarkable portfolio of 24 patents, his work paves the way for advancements in pharmaceutical synthesis and industrial applications.

Latest Patents: Among his latest achievements, Zard developed a groundbreaking process for the synthesis of agomelatine. The innovative methods involved in the industrial synthesis of this compound highlight his expertise in the field and showcase his dedication to advancing pharmaceutical chemistry.

Career Highlights: Samir Z. Zard has had a distinguished career, working with renowned companies in the chemical industry. He has contributed his extensive knowledge and skills at firms such as Rhodia Chimie and Roussel Uclaf, where he has played a key role in driving innovation and enhancing production processes.

Collaborations: Throughout his career, Zard collaborated with notable coworkers like Dominique Charmot and Mathias Destarac. These partnerships exemplify his ability to work within teams, fostering an environment of innovation and shared knowledge to address complex challenges in chemical synthesis.

Conclusion: Samir Z. Zard stands as a significant figure in the realm of chemical inventions, with a focus on the synthesis of vital compounds such as agomelatine. Through his patents and collaborations, he continues to impact the pharmaceutical industry, reinforcing his legacy as an inventor committed to innovation and progress.

Profile summary based on public USPTO records.